Global Travel Vaccines Market Growth at CAGR of 6.
Post# of 301275
Dublin, Dec. 16, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Global Travel Vaccines Market 2016-2020" report to their offering. The global travel vaccines market to grow at a CAGR of 6.83% during the period 2016-2020. The report also considers the revenues to be generated from the sales of vaccines that are expected to be launched into the market during the forecast period. The report also includes a discussion of the key vendors operating in this market.
The report covers the present scenario and the growth prospects of the global travel vaccines market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of various vaccines administered to actively immunize meningococcal disease, Japanese encephalitis, rabies, typhoid, yellow fever, hepatitis B, and hepatitis A.
R&D is budding due to a strong need for new efficacious and better tolerated vaccines. The market presents huge growth potential for vendors because of the growing incidence of infectious disease. This requirement is creating a demand for novel vaccines where major players are focusing their R&D efforts and once launched, should become the major growth drivers. Increased investment in R&D by major pharmaceutical companies would fuel the growth of the global travel vaccines market.
According to the report, the growing demand for vaccines among international travelers is one of the major factors driving the market growth. Many international and national bodies have mandated that the immigrants should be vaccinated before traveling to disease-prone areas. Considering vaccines are largely perceived as a prevention mechanism against the spread of any infectious disease; it is making a specific requirement in international traveler's list.
Further, the report states that vaccines are temperature sensitive in nature and hence, need to be kept under adequately controlled temperature throughout their supply chain. To avoid any loss of potency during its distribution, vaccines need to be kept in 'vaccine cold chain', which includes refrigerators or freezers. Inadequately stored vaccines lose their efficacy to protect against diseases and can lead to increased local reactions.
Key vendors
- GlaxoSmithKline
- Merck
- Pfizer
- Sanofi
Other prominent vendors
- Abbott
- AstraZeneca
- Bavarian Nordic
- Baxter
- Beijing Minhai Biotechnology
- Bharat Biotech
- Bharat Immunologicals and Biologicals
- Bio-Med
- Seqirus CSL
- Crucell
- CSL
- Dynavax Technologies
- Emergent BioSolutions
- GlycoVaxyn
- GreenSignal Bio Pharma
- Hualan Biological Engineering
- Imunoloski Zavod
- Indian Immunologicals
- Janssen Pharmaceuticals
- LG Life Sciences
- Lupin
- Mitsubishi Tanabe Pharma
- Novavax
- Nuron Biotech
- Panacea Biotec
- Pfizer
- Protein Sciences
- Roche
- SK Chemicals
- Sinovac Biotech
- Takeda Pharmaceutical
- Vacunas Finlay
- Valeant Pharmaceuticals
- Valneva,
- Zydus Cadila
Key Topics Covered: Part 01: Executive summary Part 02: Scope of the report Part 03: Market research methodology Part 04: Introduction Part 05: Regulatory scenario of vaccines Part 06: Market landscape Part 07: Market segmentation by disease type Part 08: Market segmentation by composition Part 09: Geographical segmentation Part 10: Market drivers Part 11: Impact of drivers Part 12: Market challenges Part 13: Impact of drivers and challenges Part 14: Market trends Part 15: Vendor landscape Part 16: Key vendor analysis Part 17: Appendix For more information about this report visit http://www.researchandmarkets.com/research/9z...bal_travel
CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Related Topics: Travel and Tourism, Vaccines
(0)
(0)